{"id":"W3029263776","doi":"10.1200/jco.2020.38.15_suppl.e21680","title":"Phase I dose escalation study of immunoconjugate L-DOS47 in combination with pemetrexed/carboplatin in non-squamous non-small cell lung cancer (NSCLC) patients.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Pemetrexed; Carboplatin; Medicine; Lung cancer; Internal medicine; Gemcitabine; Oncology; Cancer; Pharmacology; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005178745,0.000920482,0.0014867,0.0004248998,0.0002822947,0.000787863,0.0006853761,0.000790044,0.002269176],"category_scores_gemma":[0.0003519462,0.0004895985,0.0008967539,0.0003449647,0.0006694114,0.0005276391,0.0003308365,0.001853301,0.0005946995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007519274,"about_ca_system_score_gemma":0.001027743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008880038,"about_ca_topic_score_gemma":0.001821219,"domain_scores_codex":[0.9997862,0.00007401561,0.00001067927,0.00004363362,0.00002591708,0.00005958528],"domain_scores_gemma":[0.9997579,0.00002402505,0.00005679783,0.00002963655,0.000019829,0.0001117077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4029301,0.1681812,0.009023862,0.00115989,0.00155416,0.0003349787,0.0006915852,0.005886803,0.274102,0.0005289124,0.003674352,0.1319321],"study_design_scores_gemma":[0.1540518,0.798357,0.01424829,0.00003895057,0.0005260609,0.0003177421,0.000149831,0.001648549,0.02608177,0.000152547,0.004396083,0.00003131638],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962236,0.0007329928,0.0003363287,0.0001337697,0.00005838338,0.001247835,0.0002942463,0.00006142759,0.0009113156],"genre_scores_gemma":[0.9942725,0.00088709,0.000837925,0.0002055076,0.00004452015,0.001163369,0.0006783592,0.00001901596,0.001891699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002269176,"threshold_uncertainty_score":0.007591188,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03141047358839901,"score_gpt":0.371250536843823,"score_spread":0.339840063255424,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}